These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6446011)

  • 1. Effect of isoniazid on cerebrospinal fluid and plasma GABA levels in Huntington's disease.
    Manyam NV; Hare TA; Katz L
    Life Sci; 1980 Apr; 26(16):1303-8. PubMed ID: 6446011
    [No Abstract]   [Full Text] [Related]  

  • 2. Isoniazid-induced elevation of CSF GABA levels and effects on chorea in Huntington's disease.
    Manyam BV; Katz L; Hare TA; Kaniefski K; Tremblay RD
    Ann Neurol; 1981 Jul; 10(1):35-7. PubMed ID: 6455963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoniazid-induced alteration of CSF neurotransmitter amino acids in Huntington's disease.
    Manyam BV; Ferraro TN; Hare TA
    Brain Res; 1987 Apr; 408(1-2):125-30. PubMed ID: 2885064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid acetylcholinesterase and choline measurements in Huntington's disease.
    Manyam BV; Giacobini E; Colliver JA
    J Neurol; 1990 Aug; 237(5):281-4. PubMed ID: 2146369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GABA levels in cerebrospinal fluid of patients with Huntington's chorea: a preliminary report.
    Glaeser BS; Vogel WH; Oleweiler DB; Hare TA
    Biochem Med; 1975 Apr; 12(4):380-5. PubMed ID: 126061
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lumbar cerebrospinal fluid levels of GABA, HVA and 5HIAA in various patients with choreic movement and effects with isoniazid treatment].
    Yamamoto M; Otsuki S; Miyake K; Namba R
    No To Shinkei; 1983 May; 35(5):483-8. PubMed ID: 6194804
    [No Abstract]   [Full Text] [Related]  

  • 7. Isoniazid therapy of Huntington disease.
    Perry TL; Wright JM; Hansen S; MacLeod PM
    Neurology; 1979 Mar; 29(3):370-5. PubMed ID: 156313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free and conjugated GABA in human cerebrospinal fluid: effect of degenerative neurologic diseases and isoniazid.
    Manyam BV; Tremblay RD
    Brain Res; 1984 Jul; 307(1-2):217-23. PubMed ID: 6235893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Huntington's disease. Cerebrospinal fluid GABA levels in at-risk individuals.
    Manyam NV; Hare TA; Katz L; Glaeser BS
    Arch Neurol; 1978 Nov; 35(11):728-30. PubMed ID: 152621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevation of gamma-aminobutyric acid in human brain may increase dopaminergic neuronal function.
    Perry TL; Ito M; Jones K; Hansen S
    Neurosci Lett; 1984 Sep; 50(1-3):67-71. PubMed ID: 6238245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Huntington's disease: treatment with muscimol, a GABA-mimetic drug.
    Shoulson I; Goldblatt D; Charlton M; Joynt RJ
    Ann Neurol; 1978 Sep; 4(3):279-84. PubMed ID: 152602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea.
    Bonnet AM; Tell G; Schechter PJ; Grove J; Saint-Hilaire MH; De Smet Y; Agid Y
    Mov Disord; 1987; 2(2):117-23. PubMed ID: 2973560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of isoniazid therapy in Huntington disease.
    McLean DR
    Neurology; 1982 Oct; 32(10):1189-91. PubMed ID: 6214730
    [No Abstract]   [Full Text] [Related]  

  • 14. Cerebrospinal fluid gamma-aminobutyric acid variations in neurological disorders.
    Enna SJ; Stern LZ; Wastek GJ; Yamamura HI
    Arch Neurol; 1977 Nov; 34(11):683-5. PubMed ID: 143928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoniazid and Huntington's chorea.
    Perry TL
    N Engl J Med; 1978 May; 298(19):1092-3. PubMed ID: 148007
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: Low GABA levels in CSF in Huntington's chorea.
    Glaeser BS; Hare TA; Vogel WH; Olewiler DB; Beasley BL
    N Engl J Med; 1975 May; 292(19):1029-30. PubMed ID: 235093
    [No Abstract]   [Full Text] [Related]  

  • 17. Brain amino compounds in a Huntington's disease patient on isoniazid therapy.
    Perry TL; Wall RA; Hansen S
    Neurology; 1985 May; 35(5):755-8. PubMed ID: 3157886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GABA and movement disorders.
    Marsden CD; Sheehy MP
    Adv Biochem Psychopharmacol; 1981; 30():225-34. PubMed ID: 6460427
    [No Abstract]   [Full Text] [Related]  

  • 19. Free and conjugated CSF and plasma GABA in Huntington's chorea.
    Uhlhaas S; Lange H; Wappenschmidt J; Olek K
    Acta Neurol Scand; 1986 Oct; 74(4):261-5. PubMed ID: 3028028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma-aminobutyric acid (GABA) in cerebrospinal fluid.
    Kuroda H
    Acta Med Okayama; 1983 Jun; 37(3):167-77. PubMed ID: 6224397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.